We are live on ! Find out more
VKTX icon

Viking Therapeutics

140 hedge funds and large institutions have $230M invested in Viking Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $8.28M | Put options by funds: $2.76M

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

1% more funds holding

Funds holding: 138140 (+2)

1.04% less ownership

Funds ownership: 55.42%54.37% (-1%)

21% less capital invested

Capital invested by funds: $290M → $230M (-$60M)

31% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 49

Holders
140
Holders Change
+2
Holders Change %
+1.45%
% of All Funds
2.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
34
Reduced
49
Closed
14
Calls
$8.28M
Puts
$2.76M
Net Calls
+$5.52M
Net Calls Change
-$4.34M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
76
JP Morgan Chase
New York
$145K +$16.5K +2,390 +11%
VOYA Investment Management
77
VOYA Investment Management
Georgia
$136K
IWM
78
IHT Wealth Management
Illinois
$135K
State Board of Administration of Florida Retirement System
79
State Board of Administration of Florida Retirement System
Florida
$128K
Qube Research & Technologies (QRT)
80
Qube Research & Technologies (QRT)
United Kingdom
$126K -$123K -17,825 -45%
WS
81
Wedbush Securities
California
$125K +$17.2K +2,500 +13%
Stifel Financial
82
Stifel Financial
Missouri
$119K +$4.74K +689 +3%
SFI
83
Susquehanna Fundamental Investments
Pennsylvania
$116K -$13.1K -1,900 -9%
ASRS
84
Arizona State Retirement System
Arizona
$115K +$34.2K +4,974 +34%
HR
85
Hayden Royal
North Carolina
$114K -$3.15K -458 -2%
IGGA
86
Iron Gate Global Advisors
Utah
$111K +$5.51K +800 +4%
CIP
87
Cornerstone Investment Partners
Georgia
$104K
CL
88
CSS LLC
Illinois
$99K -$6.89K -1,000 -6%
OAM
89
Oppenheimer Asset Management
New York
$92K -$3.58K -520 -3%
BNP Paribas Financial Markets
90
BNP Paribas Financial Markets
France
$89.3K +$39.5K +5,740 +60%
Principal Financial Group
91
Principal Financial Group
Iowa
$86K -$5.01K -728 -5%
LPL Financial
92
LPL Financial
California
$84K -$27.5K -4,000 -22%
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$83K -$51K -7,409 -34%
SFWA
94
Summit Financial Wealth Advisors
Louisiana
$83K +$102K +14,879 New
CPA
95
Court Place Advisors
Maryland
$80K
KAS
96
Kestra Advisory Services
Texas
$74K +$87.4K +12,700 New
Citigroup
97
Citigroup
New York
$73K -$438K -63,581 -84%
IFWM
98
Institute for Wealth Management
Colorado
$71K +$1.27K +184 +2%
AG
99
Aperio Group
California
$70K +$82.5K +11,980 New
Thrivent Financial for Lutherans
100
Thrivent Financial for Lutherans
Minnesota
$66K

VKTX Hedge Fund Activity: Q3 2020 in Review

140 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2020, worth a combined $230M — down 21% from $290M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VKTX positions and 14 closed out — a net gain of 3 holders — while 34 added to existing stakes and 49 trimmed.

The largest buyer was State Street, adding an estimated $5.38M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $3.27M.

  • 140 institutional investors held Viking Therapeutics (VKTX) as of Q3 2020, up from 138 in Q2 2020.
  • Funds reported $230M of Viking Therapeutics stock for Q3 2020, down 21% quarter-over-quarter.
  • 17 funds opened new Viking Therapeutics positions in Q3 2020 and 14 closed out, a net change of +3 holders.
  • The largest Viking Therapeutics buyer in Q3 2020 was State Street, an estimated $5.38M added.
  • The largest Viking Therapeutics seller in Q3 2020 was ArrowMark Colorado Holdings, an estimated $3.27M sold.

Based on aggregated 13F filings for Q3 2020.